Private equity firm Birch Hill completes purchase of Rexall and Well.ca
Advertisement
Read this article for free:
or
Already have an account? Log in here »
To continue reading, please subscribe:
Monthly Digital Subscription
$0 for the first 4 weeks*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*No charge for 4 weeks then price increases to the regular rate of $19.00 plus GST every four weeks. Offer available to new and qualified returning subscribers only. Cancel any time.
Monthly Digital Subscription
$4.75/week*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Billed as $19 plus GST every four weeks. Cancel any time.
To continue reading, please subscribe:
Add Free Press access to your Brandon Sun subscription for only an additional
$1 for the first 4 weeks*
*Your next subscription payment will increase by $1.00 and you will be charged $16.99 plus GST for four weeks. After four weeks, your payment will increase to $23.99 plus GST every four weeks.
Read unlimited articles for free today:
or
Already have an account? Log in here »
Hey there, time traveller!
This article was published 31/12/2024 (346 days ago), so information in it may no longer be current.
Toronto-based private equity firm Birch Hill Equity Partners has completed its acquisition of the Rexall Pharmacy Group.
Birch Hill acquired the drugstore chain from previous owner McKesson Corp. in a transaction that closed Dec. 30, according to documents filed with the federal Competition Tribunal.
Financial terms of the deal, which was first announced in September, have not been disclosed.
Rexall operates 385 pharmacies across Canada and employs about 8,000 people.
As part of the deal, Birch Hill also acquires Texas-based McKesson’s Well.ca business, which offers more than 40,000 health and wellness products online.
McKesson says divesting Rexall and Well.ca will allow it to focus on expanding its oncology and biopharma growth platforms.
This report by The Canadian Press was first published Dec. 31, 2024.